受强制性开放获取政策约束的文章 - Victoria (Shu) Zhang了解详情
可在其他位置公开访问的文章：6 篇
Trends in buprenorphine treatment in the United States, 2009-2018
M Olfson, VS Zhang, M Schoenbaum, M King
Jama 323 (3), 276-277, 2020
强制性开放获取政策： US National Institutes of Health, Canadian Institutes of Health Research
Buprenorphine Treatment By Primary Care Providers, Psychiatrists, Addiction Specialists, And Others: Trends in buprenorphine treatment by prescriber specialty-primary care …
M Olfson, V Zhang, M Schoenbaum, M King
Health Affairs 39 (6), 984-992, 2020
强制性开放获取政策： US National Institutes of Health
Opioid and benzodiazepine coprescribing in the United States before and after US Food and Drug Administration boxed warning
VS Zhang, M Olfson, M King
JAMA psychiatry 76 (11), 1208-1210, 2019
强制性开放获取政策： US National Institutes of Health
Tie decay and dissolution: Contentious prescribing practices in the prescription drug epidemic
V Zhang, MD King
Organization Science 32 (5), 1149-1173, 2021
强制性开放获取政策： US National Institutes of Health
Changes in buprenorphine treatment after medicaid expansion
M Olfson, V Zhang, M King, R Mojtabai
Psychiatric Services 72 (6), 633-640, 2021
强制性开放获取政策： US National Institutes of Health
Where is all the deviance? Liminal prescribing and the social networks underlying the prescription drug crisis
V Zhang, AC Mohliver, M King
Administrative Science Quarterly 68 (1), 228-269, 2023
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定